Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer.
Anestis A, Sarantis P, Theocharis S, Zoi I, Tryfonopoulos D, Korogiannos A, Koumarianou A, Xingi E, Thomaidou D, Kontos M, Papavassiliou AG, Karamouzis MV.
Anestis A, et al. Among authors: thomaidou d.
J Cancer Res Clin Oncol. 2019 May;145(5):1221-1233. doi: 10.1007/s00432-019-02872-9. Epub 2019 Feb 25.
J Cancer Res Clin Oncol. 2019.
PMID: 30805773